To
use experimental and mathematical tools of cellular and molecular bioengineering for identification of the mechanisms for important cardiovascular diseases, for example hypertension, diabetes, stroke, myocardial infarction, venous disease, lymph edema, and physiological shock.
To
develop new tools for interventions against these diseases